Skip to main content
letter
. 2015 Jul;100(7):e265–e268. doi: 10.3324/haematol.2014.120824

Figure 2.

Figure 2.

Association between elevated ROS and better prognosis. (A) Kaplan-Meier analysis of correlation between mean CM-H2DCFDA fluorescence (GeoMFI), as a measure of ROS, and time to first treatment (TTFT). (B) Kaplan-Meier analysis of correlation between IGHV mutation status and TTFT within the cohort of patients studied.